Aratana Therapeutics, Inc.
(NASDAQ : PETX)

( )
PETX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
0.20%191.142.8%$352.70m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-1.85%25.182.1%$299.86m
ZTSZoetis, Inc. Class A
-0.08%92.091.9%$236.64m
MYLMylan N.V.
0.89%38.753.2%$214.61m
TXMDTherapeuticsMD, Inc.
1.46%5.5527.8%$14.80m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
0.88%34.522.0%$11.10m
ABEOAbeona Therapeutics, Inc.
4.03%14.207.9%$6.80m
TAROTaro Pharmaceutical Industries Ltd.
-0.42%109.056.3%$4.85m
KINKindred Biosciences, Inc.
2.44%14.700.3%$2.90m
LFVNLifeVantage Corporation
0.52%11.523.3%$2.76m
PETXAratana Therapeutics, Inc.
2.35%5.239.0%$1.54m
BSPMBioStar Pharmaceuticals, Inc.
0.50%2.0111.8%$1.26m
JAGXJaguar Animal Health, Inc.
1.06%0.860.7%$0.08m
CPHIChina Pharma Holdings, Inc.
3.78%0.230.1%$0.03m

Company Profile

Aratana Therapeutics, Inc. operates as a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets or pet therapeutics. It delivers prescription medicines that address significant medical needs for cats and dogs. The firm licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.